logo
A new Covid variant Nimbus aka ‘razor blade throat' is on the rise. All you need to know

A new Covid variant Nimbus aka ‘razor blade throat' is on the rise. All you need to know

Indian Express5 hours ago

India is witnessing a fresh uptick in COVID-19 cases, with over 7,000 active infections and more than 70 deaths reported recently. While SARS-CoV-2 has become a recurring seasonal presence, much like influenza, a new variant, NB.1.8.1, nicknamed 'Nimbus', is drawing global attention for its unusually painful symptom: a sore throat that some are describing as feeling like 'razor blades.' Indian doctors confirm that a few patients have reported this distressing feature.
Where has the Nimbus spread?
The NB.1.8.1 variant has spread rapidly across China and Hong Kong, and cases have now been detected in several US states, including California, Washington, Virginia, and New York, according to an Associated Press report. Australia has also recorded cases. In the UK, 13 cases were confirmed in June, accompanied by a nearly 10 per cent rise in hospitalisations, The Independent reported. The variant and symptoms have also been detected in India.
By mid-May, NB.1.8.1 accounted for nearly 11 per cent of all sequenced COVID samples globally, signaling a rapid rise in circulation.
What are the symptoms?
The most reported and defining symptom of the Nimbus variant is a severely painful sore throat. Other symptoms include fever, chills, cough, shortness of breath, and loss of taste or smell. However, the World Health Organization (WHO) has stated that the variant does not appear to cause more severe illness than previous strains and is currently considered low risk.
What has WHO said?
The WHO has classified NB.1.8.1 as a 'variant under monitoring,' indicating that while it is spreading, it doesn't yet pose a major threat. The organisation has also confirmed that current COVID-19 vaccines remain effective in preventing severe outcomes linked to the variant.
'The WHO assesses the additional risk to the global public as currently low, and existing COVID-19 vaccines are considered effective in preventing severe disease,' Dr Naveed Asif, a general practitioner at The London General Practice, told The Independent.
Which vaccines offer protection?
Vaccines approved by the US FDA – Moderna, Pfizer-BioNTech, and Novavax – are expected to be effective against NB.1.8.1, especially because it belongs to the Omicron JN.1 lineage. An article by New York-Presbyterian/Columbia University Irving Medical Center stresses the importance of staying up-to-date with boosters.
Those with underlying health conditions like diabetes, heart disease, or hypertension should take extra precautions, as their immune response may not be as robust.
Why Nimbus spreads faster
Scientists believe NB.1.8.1 may spread more efficiently due to stronger binding with human cells. A Gavi report noted that the variant binds tightly to the ACE2 receptor, which SARS-CoV-2 uses to enter the body.
'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested,' said virologist Lara Herrero from Griffith University in The Conversation, 'suggesting it may infect cells more efficiently than earlier strains.'
Dr Chun Tang, a general practitioner at UK-based Pall Mall Medical, added that while the variant isn't drastically different from Omicron, 'some tweaks to its spike protein' may make it more transmissible or help it evade immunity.
'What sets NB.1.8.1 apart is how quickly it spreads,' said Dr Magdalena Sobieszczyk, Chief of Infectious Diseases at New York-Presbyterian/Columbia. 'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells.'
Prevention is key
Precautions remain largely the same. Mask up in crowded places, cover your mouth while coughing or sneezing, wash and sanitise your hands regularly, and avoid stepping out if unwell. Ventilated spaces remain safer, especially during spikes in transmission.
No, 'Nimbus' isn't a Harry Potter reference
While some may associate 'Nimbus' with the magical broomstick from 'Harry Potter' or characters from 'Rick and Morty', the nickname actually refers to a type of cloud. Professor T Ryan Gregory of the University of Guelph in Canada explained to Gavi' that naming conventions like 'Nimbus' (NB.1.8.1) and 'Stratus' (XFG) help make emerging variants easier to track and communicate to the public.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stray attacks in Kannur: Min to hold meet today
Stray attacks in Kannur: Min to hold meet today

Time of India

time42 minutes ago

  • Time of India

Stray attacks in Kannur: Min to hold meet today

1 2 3 Kannur: Amid the growing fear and public outcry following stray dog attacks on 80 people in Kannur in the last few days, minister Kadannappally Ramachandran will convene a meeting at the collectorate on Friday to discuss the menace. K Sudhakaran MP, corporation mayor Muslif Madathil, district panchayat president K K Rathnakumari, district collector Arun K Vijayan, city police commissioner P Nithin Raj as well as officials with health and animal husbandry departments, Indian Railways and Kannur Cantonment will attend. Kannur corporation held a special council meeting on Thursday to discuss the issue. The meeting witnessed a heated verbal exchange between the councillors of the ruling front and the opposition. Mayor Madathil said the corporation would set up a dedicated shelter for stray dogs and an animal birth control unit to tackle the issue. An all-party meeting will be convened to finalize the units' location, he said. Meanwhile, a five-year-old boy was admitted to the Pariyaram Govt Medical College Hospital with rabies despite being administered a vaccine. The child is now on ventilator support. The boy was bitten by a stray dog near SN Park at Payyambalam on May 31. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Indian Truck Driver Now Earns ₹2.9 Crore Monthly (See how) prestigetrophy Learn More Undo He sustained serious injuries on his face and leg. According to his parents from Tamil Nadu, the boy was rushed to the hospital and given an anti-rabies vaccination. But he developed fever and rabies symptoms before tests confirmed it. 5 students attacked in Idukki Five students of Devikulam Tamil Higher Secondary School were injured in a stray dog attack on Thursday. While they were attacked on their way to school in the morning near its premises, Mahendran, another student, was reportedly bitten on Wednesday evening. The injured were admitted to Adimali taluk hospital.

Foreign medical graduates allowed internship at ESIC
Foreign medical graduates allowed internship at ESIC

Time of India

time42 minutes ago

  • Time of India

Foreign medical graduates allowed internship at ESIC

Jaipur: The medical education department resolved the issue of 100 foreign medical graduates (FMGs) who were denied internships at ESIC Alwar due to certain technical issues. TOI highlighted the issue, 'Foreign medical graduates' internship in limbo over stipend row, limited seats,' published on June 17, following which the ESIC Medical College allowed the foreign medical graduates to undertake internships following state govt clarification on the issue. Out of 100 FMGs, 99 joined on Thursday, while one FMG, who is in China, was unable to join. The primary obstacle appears to be a complex web of a limited number of seats, regulatory requirements, and stipend-related issues. A day after the story was published, medical education department consulted with ESIC Medical College and discussed the issue. The medical college administration expressed that there is a technical issue that needs to be resolved related to the stipend to interns and the limited seats available for internships. With 100 internship seats available and an equal number of Indian medical graduates already competing for the same positions, the institution faces a significant logistical challenge. Besides, the medical college discussed the Supreme Court ruling on stipends for all interns, but the National Medical Commission allows for only 7.5% of the total internship seats. "State govt has given clarification on the issue. The govt allowed giving a stipend to 7.5% of the interns, and for the rest of the students, the govt asked us to take an undertaking from them that they do not need a stipend. Based on this clarification from the govt, the interns have joined the internship by giving the undertaking," said Dr Asim Das, Dean of ESIC Medical College. ESIC Medical College is worried that in May 2026, another batch of 100 interns will join.

Step up to the global vaccine plate
Step up to the global vaccine plate

Economic Times

timean hour ago

  • Economic Times

Step up to the global vaccine plate

Agencies Representational The Modi government is under pressure from the domestic vaccine industry to substantially increase its financial investment in Gavi (formerly, Global Alliance for Vaccines and Immunisation), the Vaccine Alliance, threatened by the prospect of its largest-by-far donor, the US, under Trump 2.0 pulling the plug on the PPP that helps vaccinate half the world's children against some of the deadliest diseases. Gavi is now desperately looking at large emerging economies like China and India, along with Gulf states, to make up the shortfall. For New Delhi, it's an opportunity to help local vaccine manufacturers heavily involved in Gavi, and also boost India's role as a major global current fiscal predicament is an outcome of Trump, ironically a champion of the alliance in his first term when he pledged a generous $1.1 bn for 2020-23. But in an extraordinary somersault, Trump 2.0 has suspended all external funding, including for global health, pulled out of WHO, and appears to be reneging on an earlier pledge to Gavi by the Biden administration one year ago of $1.58 bn over a period of five years. Significantly, the Trump regime's FY26 budget request to Congress and senate now being debated indicates drastic reductions in funding for global health. It does not even include funding for Gavi. To make matters worse, US secretary of health Robert F Kennedy Jr is a vaccine-sceptic who has questioned the efficacy and safety of vaccines. A vocal critic of Gavi, Kennedy has made numerous public statements and written articles expressing concerns about the organisation's transparency, accountability and impact on global health. India has had a special relationship with Gavi for long. In 2014, it was the first recipient country to become a donor to the alliance formed at the start of the new millennium with the help of core partners WHO, Unicef, World Bank, and the Bill and Melinda Gates Foundation, along with solemn pledges of support from a host of developed nations led by the US. As the Indian vaccine industry grew in leaps and bounds over the past decade, local manufacturers today represent over 50% of Gavi's vaccine procurement by volume. In terms of value, Gavi has procured 3 bn doses worth $3 bn from Indian manufacturers during 2016-24. Worried at the impact on India by Gavi's financial crisis, Indian Vaccine Manufacturers Association (IVMA) appealed to the PM, FM and health minister, among others, urging GoI to come to Gavi's aid. 'India has long benefited from Gavi's programmes, both in terms of access to life-saving vaccines and through support for the export of vaccines manufactured by Indian companies. A reduction in Gavi's funding would, therefore, adversely impact our export ecosystem, restrict market access, and challenge our shared mission to advance global health equity,' their letter said. It urged GoI to consider a 'financial contribution of $260 mn annually for the next 5 years to bridge the impending funding gap and support Gavi's continued efforts'. Such a commitment, IVMA believes, would reinforce India's global leadership in health diplomacy, and its image as a champion of multilateral institutions and 'global south-south' cooperation. This, along with sustaining the global reach of Indian vaccines that is crucial for the domestic manufacturing ecosystem. Such an increase in financial commitment to Gavi from the current $15 mn - although quadrupled in less than a decade from India's contribution when it first became a donor - may be difficult for GoI. This is particularly so when it's dealing with financial challenges posed by the burden of importing expensive military hardware and Donald Trump's tariff demands. A more realistic financial commitment expected from India would be around $100 mn. Over the past decade, one area India has gained considerable respect in is the global health space, particularly during the pandemic when the country significantly contributed with its vaccine manufacturing abilities to the worldwide effort to cope with an unparalleled health crisis. India recently became the world's third-largest economy, surpassing Japan. But the latter gives as much as $1.54 bn in total contributions and pledges, while China's contribution is $120 China poised to fill the vacuum left in global health and other development initiatives by an increasingly isolationist US, India would do well to weigh the gains of protecting a vital domestic industry, as well as promoting strategic global outreach against the financial burden. Health minister J P Nadda, a former Gavi board member, will be India's representative at the organisation's pledging summit in Brussels next week. It could be an opportune moment for India to punch its weight on the global healthcare front. The writer is an independent journalist (Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Why Infy's Parekh takes home more than TCS' CEO despite being smaller Central bankers print currency for all, but why do they chase gold? Worrying cracks hiding behind MG Motor's own 'house of Windsor' Why failed small businessmen die by suicide when those behind big blow-ups bounce back? Stock Radar: Ascending Triangle pattern breakout makes Mphasis an attractive buy; stock up over 30% from April lows Buy, Sell or Hold: BSE doubles from March lows, but brokerages turn cautious after SEBI's expiry day directive These mid-cap stocks with 'Strong Buy' & 'Buy' recos can rally over 25%, according to analysts F&O Radar| Deploy Bear Put Spread in Nifty for gains from volatility, negative stance

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store